The vector of anti-MART-1(DMF5) chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human MART-1(DMF5). The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-MART-1(DMF5) antibody linked to b2c and CD3-zeta signaling domains. And the vector product was designed for the treatment of metastatic melanoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-TCR-C298||Lenti-MART-1 (ELAGIGILTV) T cell receptor (DMF5) Viral Particle|
|TCR-L069||Human anti-MLANA [27–35] T Cell Receptor, pLXSN|
|VP-TCR-C284||Lenti-MART-1 (AAGIGILTV) T cell receptor (DMF5) Viral Particle|
|TCR-L067Z||Murinized anti-MART-1 (ELAGIGILTV) T cell receptor (Cysteine-modiﬁed), pCDTCR1|
|VP-TCR-C286||Lenti-MART-1 T cell receptor (DMF5(alpha-D26Y,beta-L98W)) Viral Particle|
|VP-CAR-LC337||Lenti-MART-1(DMF5) CAR (scFv-41BB-CD3ζ, Melan-A) Viral Particle|
|TCR-L071Z||Human anti-melan-A T cell receptor, pCDTCR1|
|TCR-C143Z||Human anti-MART1 T cell receptor (2C2), pCDTCR1|
|VP-TCR-C296||Lenti-MART-1 T cell receptor (α24β17) Viral Particle|
|TCR-C138Z||Murinized anti-MART1 T cell receptor (1D3HMCys), pCDTCR1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved